Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial – JAMA Commentary: Common antibiotic no more effective than placebo in preventing COVID-19 symptoms among non-hospitalized – University of California – San Francisco Related: RCT: Another study shows Azithromycin does not improve outcomes in patients with Covid-19. […]

The post RCT: more data showing Azithromycin is not better than placebo in patients with Covid-19. appeared first on Links Medicus.